TOPSPIN Study by the Centre for Chronic Disease Control (CCDC) Finds Two-drug Combination Therapies Effective in Improving Blood Pressure Control in Indians
New Delhi [India], July 30: A new study, entitled TOPSPIN, coordinated by the Centre for Chronic Disease Control (CCDC) New Delhi, in collaboration with the All India Institute of Medical Sciences (AIIMS) New Delhi, and Imperial College London, examined 1,981 patients with uncontrolled hypertension across 32 hospitals in India. The findings showed that three two-drug combination therapies - Amlodipine plus Perindopril, Amlodipine plus Indapamide, and Perindopril plus Indapamide - were equally effective and safe in lowering both ambulatory and office blood pressure. TOPSPIN is the first-ever randomised study to test the choice of first-line two-drug combination therapy in a single pill among South Asians. The study findings are published in Nature Medicine, one of the top medicine journals.
South-Asians represent one-fourth of the world population, and India alone constitutes one-sixth of the global population. Hypertension is a public health crisis affecting over one billion adults worldwide, including over 300 million living in India. Innovative solutions are needed to curb the growing tide of high blood pressure, which is the single highest risk factor for global deaths, and which requires effective management solutions. Current guidelines widely recommend initiating treatment with two-drug combinations, preferably in a single-pill formulation, to enhance blood pressure control. However, the suitability of these combinations for the South-Asian population remains unknown, as there are no studies in this regard.
The key takeaways are that all three combinations were equally effective in reducing blood pressure and were safe for patients.
What did the TOPSPIN study find?
- Blood pressure dropped significantly after 6 months, by around 14/8 mmHg when measured over 24 hours and about 30/14 mmHg in clinic settings.
- Nearly 70% of patients reached the recommended blood pressure target below 140/90 mmHg, five times higher than India's current average control rate.
- The pills were well-tolerated, with less than 3% of patients reporting side effects serious enough to stop treatment.
What do the Study leaders say?
"This study shows that a single daily pill with two drugs can be a simple and powerful way to manage blood pressure in Indian and South Asian patients," said Prof. Dorairaj Prabhakaran, Executive Director of CCDC and one of the study's lead authors. "These findings can help guide doctors and policymakers. If added to India's list of essential medicines and made available at primary health centres, these pills could greatly improve blood pressure control in the country."
Prof. Ambuj Roy, Professor of Cardiology at AIIMS Delhi, added, "Nearly 70% of patients got their blood pressure under control, a huge improvement over the current national average. And the pills were safe and easy to use. This study gives clear guidance for better hypertension care."
Prof. Neil Poulter, Professor at Imperial College London, emphasized the importance of studying how medicines work in different populations. "Just as earlier research in Africa showed different results, this study gives strong evidence on what works best in South Asians."
The TOPSPIN study results could help improve treatment not only in India, but also for South Asians living around the world.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
2 days ago
- Hans India
AIIMS-led study shows two-medicine combination therapy effective in controlling high BP
Using a single pill comprising two blood pressure medicines is a safe and highly effective way to treat hypertension among South Asians, particularly Indians, finds a study led by the All India Institute of Medical Sciences (AIIMS), New Delhi. The study, in partnership with the Centre for Chronic Disease Control (CCDC) and Imperial College London, UK, compared three widely used drug combinations: amlodipine plus perindopril, amlodipine plus indapamide, and perindopril plus indapamide. The first randomised trial to test three different two-drug combination pills among South Asians involved over 1,200 patients with uncontrolled hypertension across 32 hospitals in India. 'All three combinations worked equally well in reducing blood pressure and were safe for patients,' revealed the study, published in the journal Nature Medicine. The findings showed that either of the two-drug combinations led to a significant drop in blood pressure after 6 months -- by around 14/8 mmHg when measured over 24 hours and about 30/14 mmHg in clinic settings. 'Nearly 70 per cent of patients got their blood pressure under control, a huge improvement over the current national average. And the pills were safe and easy to use. This study gives clear guidance for better hypertension care,' said Dr Ambuj Roy, Professor of Cardiology at AIIMS Delhi. 'This study shows that a single daily pill with two drugs can be a simple and powerful way to manage blood pressure in Indian and South Asian patients,' said Dr Dorairaj Prabhakaran, Executive Director of CCDC. High blood pressure (hypertension) is the leading risk factor for death worldwide and affects over 300 million people in India alone. Treating it early and effectively can prevent heart attacks, strokes, and kidney failure. Doctors often recommend starting with two medications in one pill to control blood pressure better and help patients stick to treatment. But until now, no large study had tested which combinations worked best for South Asians, who make up a quarter of the world's population. The results revealed that nearly 70 per cent of patients with any of the dual drug therapy reached the recommended blood pressure target of below 140/90 mmHg -- five times higher than India's current average control rate. Less than 3 per cent of patients reported side effects serious enough to stop treatment. 'These findings can help guide doctors and policymakers. If added to India's list of essential medicines and made available at primary health centres, these pills could greatly improve blood pressure control in the country,' Prabhakaran said.
Business Standard
3 days ago
- Business Standard
Nutrica by BN Group Forays into the Honey Category with Function-first Nutrica Bee Honey
NewsVoir New Delhi [India], August 1: Nutrica, a lifestyle and wellness brand by BN Holdings Limited, the flagship company of the INR 9,000 Crore BN Group founded by visionary Anubhav Agarwal, has forayed into the honey category with the launch of Nutrica Bee Honey. It is a range of purpose-led variants designed for energy, fitness, and immunity and is now available across general trade stores in Delhi NCR and Mumbai. Health-conscious living is rapidly becoming a priority for millions. Nutrica's move into honey comes at a pivotal moment. The brand, already known for function-first cooking oils, now extends its wellness promise through a superfood that's been embedded in Indian diets for centuries, honey. Nutrica Bee Honey introduces a purposeful spin on this traditional favourite, offering three targeted variants designed to meet the needs of today's increasingly health-driven, active households. Nutrica Bee Honey comes in three purpose-led variants. Pro-Energy Multiflora Honey blends nectar from diverse flora, naturally rich in antioxidants and nutrients, to provide sustained energy throughout the day. Pro-Fitness Lemon Infused Honey combines honey's natural sweetness with the zest of lemon to support digestion, metabolism, and weight management. Pro-Immunity Tulsi Infused Honey draws on the medicinal properties of Tulsi to help strengthen immunity and ease common coughs and colds. All variants are free from artificial preservatives and added sugar, sourced from regions abundant in natural flora, and rigorously tested for purity and authenticity. Staying true to its ideology of Building Nation, Nutrica ensures that each jar delivers clean, functional nutrition while continuing the brand's commitment to purposeful health solutions. "Nutrica Bee Honey is not just a new product, it's an extension of who we are and what we stand for," said Sparsh Sachar, Director and Business Head, FMCG, Nutrica. "We have built Nutrica to support modern, active lifestyles with products rooted in both tradition and innovation. With our honey range, we're offering a clean, natural solution that aligns with evolving wellness needs. It's these purposeful choices that reflect the larger commitment BN Group has always upheld, creating everyday essentials that help nurture healthier communities." The launch strengthens Nutrica's function-first portfolio, which includes vitamin C-enriched cooking oils, and reflects the company's commitment to purposeful, everyday wellness solutions. BN Group, founded by visionary Anubhav Agarwal, has long championed creating high-quality essentials that promote better living. With a pricing strategy that is premium yet accessible, Nutrica aims to bring the benefits of high-quality honey to a wider base of Indian households. This debut also marks a key step in the brand's vision of expanding further into the natural and functional food space, delivering products that help consumers live healthier every day. Nutrica, a leading edible oil brand under BN Holdings Limited, carries a mission to reimagine health by crafting innovative and nutritious oils that cater to the diverse needs and preferences of families across India. Understanding that every family is unique, the company is dedicated to creating nutrient-infused oils that fulfil the health goals and taste preferences of its customers. The oils are made from the finest ingredients and cutting-edge technology, ensuring the highest standards of quality and nutrition.
Business Standard
3 days ago
- Business Standard
Modicare Unveils ShiftLife, Its New Wellness Range Under Modiway
NewsVoir New Delhi [India], August 1: In a continued effort to empower individuals in their journey towards better health and wellbeing, Modicare Limited, one of India's leading direct-selling companies, has announced the launch of Modiway Shift Life under its health & nutrition category. This all-new range marks a significant step in Modiway's commitment to offering innovative, accessible solutions that support holistic, long-term wellbeing. Curated with a deep understanding of today's fast-paced world, Shift Life offers a better way forward, through effective and science-backed products that nourish the body, support the mind, and uplift the soul. The products combine the potency of plant-based, vegan formulations, the precision of modern science, and the wisdom of Ayurveda, offering clean, effective, and easy-to-integrate solutions that address common lifestyle concerns such as fatigue, poor digestion, dull skin, low immunity, stress, and sluggish metabolism. Speaking on the launch, Mr. Samir K Modi, Founder and Managing Director, Modicare Limited, said, "I believe that the true wealth of a nation lies not only in its financial growth, but in the well-being, inner strength, and conscious living of its people. With a carefully curated range of 10 wellness products, ShiftLife is designed to support real, everyday health needs. More importantly, ShiftLife reflects the philosophy that drives Modiway, that health is not just about the physical, but about living with clarity, discipline, and intention." YouTube link: With a carefully curated range of 10 wellness products, ShiftLife is designed to support real, everyday health needs: ShiftLife Super Greens A potent blend of 40 super ingredients; greens, superfoods, fruits, veggies, herbs, and probiotics to support digestion, vitality, and immunity. ShiftLife Veg Collagen Formulated with clinically studied vegan collagen (Vegcol®), glutathione, Vit C & E, and resveratrol to promote skin elasticity, radiance, and stronger hair & nails. ShiftLife Pea Based Protein An allergen-friendly protein blend with pea, brown rice, MCTs, superfoods, and probiotics designed to support strength, stamina, and gut health. ShiftLife Probiotic Capsules A potent blend of 50 billion CFUs from 11 clinically studied strains in a daily capsule to help reset the gut, reduce bloating, and support better nutrient absorption. ShiftLife BP Balance An Ayurvedic syrup formulated with Arjuna, Haridra, Haritaki, Saunf & Akshiki Phala to support heart health and healthy blood pressure. ShiftLife Glo Boost An Ayurvedic Syrup with Kesar, Shvetachandana, Kanyasara, Haridra, Sveta Sariva, Yashtimadhu & Haritaki to promote radiant and clear skin from within. ShiftLife Metabolic Boost An Ayurvedic syrup with Amla, Tvak, Kokum, Ashwagandha, Katuki, Rakta Punarnava & Haritaki to support metabolism, digestion, and natural detox. ShiftLife Vita Liver A liver support syrup with Bhringaraja, Rakta Punarnava, Kalmegh, Katuka, Trivrita & Guduchi to aid detox, digestion, and overall liver health. ShiftLife Respiratory Care A comforting, non-drowsy, non-alcoholic syrup with Tulasi, Ginger, Yashtimadhu, Pippli, Kali Mirch, Labanga, Kantkari, & Haritaki to reduce chest congestion and support lung health. ShiftLife Himalayan Shilajit Gold with Kesar A premium proprietary formulation with Shilajit, Suvarna Bhasma, and Kesar to enhance endurance, vigour and vitality. Available exclusively through Modicare Consultants across the country and online at ShiftLife reflects the philosophy that drives Modiway, that health is not just about the physical, but about living with clarity, discipline, and intention. Modicare is one of India's leading Direct Selling Companies and the pioneer of Direct Selling industry in India. It has been empowering Indians and changing their lives since 1996. Today, the company has over 60 Lakh Direct Sellers and offers over 470+ products, 890+ SKUs across 18 categories - Personal Care, Wellness, Consumer Durables, Skin Care, Colour Cosmetics, Food & Beverage, Homecare, Auto Care, Laundry Care, Technology, 18 Karat Gold Plated Jewellery, Watches, Divine, and Agriculture. It has a national presence through its 50+ Modicare Lifestyle Centres and 11700+ Distribution Points. As part of its continued commitment to innovation and holistic well-being, Modicare introduced Modiway - The New Way. This initiative further strengthens the company's portfolio with 95+ products and 128+ SKUs across three key categories - Health & Nutrition, Beauty, and Kitchen Solutions. The Health & Nutrition category features the ShapeShift and ShiftLife ranges, priced between INR 650 and INR 4,300. The Beauty segment offers the Forest Nectar range, priced from INR 850 to INR 2,000. The Kitchen Solutions category includes the Soul Chef range, priced from INR 600 to INR 11,000. Together, Modicare and Modiway continue to inspire entrepreneurship and promote wellness in every Indian household.
